- Valuation
- ₹11,950 Cr

About BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals is a Healthcare company based in Mumbai (India) founded in 2003 by Dharmesh Shah. APIs and finished products are developed and manufactured. BDR Pharmaceuticals Internationals has raised $88.16 million across 1 funding round from investors including BKT Tires, State Bank of India and Multiples Alternate Asset Management. The company has 1,864 employees. BDR Pharmaceuticals Internationals was last valued at $950.33 million in January 2022. BDR Pharmaceuticals Internationals offers products and services including API, Formulations, and Pellets. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is BDR Pharmaceuticals Internationals Pvt. Ltd. Its competitors include Indoco Remedies, Concord Biotech and Aurobindo Pharma.
Company details
BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.
Recognitions & Rankings of BDR Pharmaceuticals Internationals
- Headquarters Mumbai, India
- Employees 1,864
- Founders Dharmesh Shah
- Stage Soonicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phoneβ’β’β’β’ β’β’β’β’
- Website bdrpharma.com
- Social LinkedIn X Facebook
- Legal Name Bdr Pharmaceuticals Internationals Pvt. Ltd.
- Annual Revenue$134.65 M (USD)8as on Mar 31, 2024
- Net Profit$28.89 M (USD)16as on Mar 31, 2024
- EBITDA$43.81 M (USD)16as on Mar 31, 2024
- Total Equity Funding$88.16M (USD)
in 1 rounds
- Latest Funding Round$88.16M (USD), Private Equity Round
Jan 2022
- InvestorsBKT Tires
& 9 more
- Employee Count1,864
Associated legal entities of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals is associated with 5 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bd-Verse Llp CIN ABA-8199 | Active | 24 Feb 2022 | Mumbai, Maharashtra | 2 | View details | ||
| Magnum Chemi-Gran Private Limited CIN U24230TG2005PTC046533 | Active | 14 Jun 2005 | Hyderabad, Telangana | ₹29.7 Cr | 53 | 5 | View details |
| Virdev Intermediates Private Limited CIN U24230GJ1994PTC021189 | Active | 01 Feb 1994 | Surat, Gujarat | ₹108 Cr | 313 | 6 | View details |
| Bdr Lifesciences Private Limited CIN U24230GJ1993PTC020258 | Active | 24 Sep 1993 | Vadodara, Gujarat | ₹177 Cr | 263 | 6 | View details |
| Bdr Pharmaceuticals International Private Limited CIN U24230MH2002PTC137329 | Active | 24 Sep 2002 | Mumbai, Maharashtra | ₹1,080 Cr | 1,437 | 8 | View details |
Products & Services of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals offers a comprehensive portfolio of products and services, including API, Formulations, and Pellets.
Manufactures niche APIs with advanced facilities for quality compliance.
Develops and markets various dosage forms for affordable healthcare.
Creates sustained-release pellets using innovative technologies.
Funding Insights of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has successfully raised a total of $88.16M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $88.16 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $88.16M
- Total Rounds 1
- Last Round Private Equity Round β $88.16M
- First Round $88.16M
(Jan 2022)
- Investors Count 10
All 1 funding rounds of BDR Pharmaceuticals Internationals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $88.16M | Private Equity Round | $950.33M | Multiples Alternate Asset Management |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2022 | $950.33M | β’β’β’β’β’β’β’β’ |
Last known valuation $950.33M (Jan 2022). 10 investors in total: 7 institutional and 3 angel.
Investors in BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BKT Tires, State Bank of India and Multiples Alternate Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment partnerships, entrepreneur support, and profit-focused services in finance. | 2009 | multiplesequity.com | Mumbai, India | |
Schools and pre-schools are established in India and abroad. | 2000 | kamaholdings.com | Gurugram, India | |
Venture capital firm focused on early-stage companies | Faridabad, India | |||
HCL Capital is engaged in impact-driven investments across sectors. | hcl-capital.com | Hong Kong, Hong Kong | ||
Off-highway tires for commercial vehicles are manufactured. | 1987 | bkt-tires.com | Mumbai, India | |
State Bank of India is engaged in providing banking and financial services. | 1955 | onlinesbi.sbi | Mumbai, India | |
NA Nishant Agarwal | Angel investor, tech entrepreneur, ex-CTO of Cred, focused on fintech | unknown_069f9fb1e23e46648 | ||
MS Mallika Srinivasan | unknown_92d65d4826544eadb | |||
NA Nishant Agarwal | Angel investor, tech entrepreneur, ex-CTO of Urban Company, active in startups | unknown_2aeba78d1ae740efa |
Investor details for BDR Pharmaceuticals Internationals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of BDR Pharmaceuticals Internationals
The boards of the 5 registered companies of BDR Pharmaceuticals Internationals currently have 16 directors; the longest-serving is Narendra Bhagwandas Jariwala, appointed in 1994. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Narendra Bhagwandas Jariwala DIN 01029286 | Director | 01 Feb 1994 | 32 yrs 9 mo | Virdev Intermediates Private Limited |
| Kaushik Bhagwandas Jariwala DIN 01029229 | Director | 12 Nov 2000 | 26 yrs | Virdev Intermediates Private Limited |
| Sanjay Amritlal Solanki DIN 01838642 | Director | 12 Nov 2000 | 26 yrs | Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited |
| Viralkumar Narendrabhai Jariwala DIN 01667767 | Director | 12 Nov 2000 | 26 yrs | Virdev Intermediates Private Limited |
| Venkata Reddy Puchakayala DIN 01851974 | Managing Director | 14 Jun 2005 | 21 yrs 5 mo | Magnum Chemi-Gran Private Limited |
| Ketan Suresh Shah DIN 03149312 | Director | 05 Jul 2010 | 16 yrs 4 mo | Bdr Lifesciences Private Limited |
| Chenna Reddy Puchakayala DIN 03198883 | Director | 02 May 2012 | 14 yrs 6 mo | Magnum Chemi-Gran Private Limited |
| Trushit Pramodray Mehta DIN 06439479 | Director | 01 Nov 2012 | 14 yrs | Bdr Lifesciences Private Limited |
| Aravind Manappa Badiger DIN 06540340 | Director | 15 Dec 2012 | 13 yrs 11 mo | Bdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited |
| Raheel Dharmesh Shah DIN 03582861 | Director | 27 Jul 2018 | 8 yrs 3 mo | Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited, Bdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited |
| Jayesh Shantilal Trivedi DIN 08980462 | Director | 04 Dec 2020 | 5 yrs 11 mo | Bdr Pharmaceuticals International Private Limited |
| Tejash Vijay Shah DIN 01862033 | Director | 19 Apr 2021 | 5 yrs 7 mo | Bdr Lifesciences Private Limited, Bdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited |
| Rupi Romil Kapadia DIN 09519200 | Designated Partner | 24 Feb 2022 | 4 yrs 8 mo | Bd-Verse Llp |
| Dheer Dharmesh Shah DIN 07937075 | Designated Partner | 24 Feb 2022 | 4 yrs 8 mo | Bd-Verse Llp, Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited |
| Manish Gaur DIN 00340911 | Nominee Director | 12 May 2022 | 4 yrs 6 mo | Bdr Pharmaceuticals International Private Limited |
| Dharmesh Mahendra Shah DIN 00452961 | Director | 13 May 2022 | 4 yrs 6 mo | Bdr Pharmaceuticals International Private Limited |
People of BDR Pharmaceuticals Internationals
7 people are tracked at BDR Pharmaceuticals Internationals (4 in leadership, 3 in team); the tracked headcount is 1,864.
| Name | Role | Group |
|---|---|---|
| Founder & Chairman | Leadership | |
| Director | Leadership | |
| Director | Leadership | |
| Director | Leadership | |
Darshan Ka Patel | Purchase Officer | Team |
Vijay Patel | Senior Executive | Team |
Mohammad Sonu | Senior Officer | Team |
Complete people profiles for BDR Pharmaceuticals Internationals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of BDR Pharmaceuticals Internationals
Figures of Virdev Intermediates Private Limited, the primary company behind BDR Pharmaceuticals Internationals, for FY 2025. Revenue was ₹108 Cr (-3% year on year). Net profit was ₹8.71 Cr (8% margin). EBITDA was ₹16.95 Cr (16% margin). Revenue has grown at a compounded annual rate of -2% over three years and +21% over five years.
- ₹108 CrRevenue · FY 2025 · -3% YoY
- ₹8.71 CrNet profit · 8% margin
- ₹16.95 CrEBITDA · 16% margin
- ₹5.41 CrPaid-up capital
- 313Employees (provident fund records)
- -2%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Virdev Intermediates Private Limited are on its company page.
Detailed financial statements for BDR Pharmaceuticals Internationals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of BDR Pharmaceuticals Internationals
3 dated milestones of BDR Pharmaceuticals Internationals across 19 years, from founding to its latest funding, stage changes and deals.
- Founded BDR Pharmaceuticals Internationals is founded.
- Funding First funding round of $88.2M.
- Milestone Reaches Soonicorn status.
Competitors of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has 3 listed competitors in our database. They include Indoco Remedies, Concord Biotech and Aurobindo Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| aurobindo.com | 1986 | Hyderabad, India | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. |
Detailed competitors of BDR Pharmaceuticals Internationals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BDR Pharmaceuticals Internationals
The website of BDR Pharmaceuticals Internationals (bdrpharma.com) receives about 3.3K visits a month and ranks #4,388,942 among all websites worldwide, #5,343 in Biotechnology and Pharmaceuticals.
- Monthly visits3.3K
▼ 18.6% vs previous month
- Unique visitors1.7K
per month
- Global rank#4,388,942
among all websites
- Category rank#5,343
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.7
- Average visit43 sec
- DevicesDesktop 38% Β· Mobile 62%
Websites whose visitors overlap most with BDR Pharmaceuticals Internationals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| samilabs.com | 100% | View details | |||
pharmexcil.com | pharmexcil.com | 94% | #794,041 | β | |
| microcellulose.com | 93% | #7,291,109 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as BDR Pharmaceuticals Internationals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bdr Pharmaceuticals Internationals
Complete news archive for BDR Pharmaceuticals Internationals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals was founded in 2003 and raised its 1st funding round 19 years after it was founded.
BDR Pharmaceuticals Internationals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
BDR Pharmaceuticals Internationals is a funded company, having raised a total of $88.16M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $88.16M, raised on Jan 2022.
BDR Pharmaceuticals Internationals has 1,864 employees.
Annual revenue of BDR Pharmaceuticals Internationals is $134.65M as on Mar 31, 2024.
BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.
BDR Pharmaceuticals Internationals's top competitors include Concord Biotech, Indoco Remedies and Aurobindo Pharma.
BDR Pharmaceuticals Internationals offers API, Formulations, and Pellets.
BDR Pharmaceuticals Internationals has 10 investors. Key investors include BKT Tires, State Bank of India, Multiples Alternate Asset Management, Kama Holdings, and Nishant Agarwal.
The valuation of BDR Pharmaceuticals Internationals is $950.33M as of Jan 2022.
BDR Pharmaceuticals Internationals is associated with 5 legal entities: Bd-Verse Llp, Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited and others.
The legal entities of BDR Pharmaceuticals Internationals currently have 18 directors, including Rupi Romil Kapadia, Dheer Dharmesh Shah, Kaushik Bhagwandas Jariwala and others.
